v3.19.3

Note 6 - Accrued Liabilities

9 Months Ended

12 Months Ended

Sep. 30, 2019

Dec. 31, 2018

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

Note 6.  Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

		December 31, 2018			September 30, 2019
Payroll and related expenses		$	241		$	640
Accrued term loan final payment			421			608
Accrued clinical trial expense			—			26
Professional fees and other costs			195			899
Total accrued liabilities		$	857		$	2,173

Note 4.     Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

		As of December 31,
		2017			2018
Payroll and related expenses		$	273		$	241
Accrued term loan final payment			197			421
Accrued clinical trial expense			654			—
Professional fees and other costs			34			195
Total accrued liabilities		$	1,158		$	857

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration